Processes for forming coordination complexes containing monosulfonated catecholate ligands
US-2017253620-A1 · Sep 7, 2017 · US
US9837679B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9837679-B2 |
| Application number | US-201514952899-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 25, 2015 |
| Priority date | Nov 26, 2014 |
| Publication date | Dec 5, 2017 |
| Grant date | Dec 5, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Active materials for flow batteries can include various coordination compounds formed from transition metals. Some compositions containing coordination compounds can include a substituted catecholate ligand having a structure of in a neutral form or a salt form, in which Z is a heteroatom functional group bound to the substituted catecholate ligand at an open aromatic ring position and n is an integer ranging between 1 and 4. When more than one Z is present, each Z can be the same or different. Electrolyte solutions can include such coordination compounds, and such electrolyte solutions can be incorporated within a flow battery.
Opening claim text (preview).
What is claimed is the following: 1. A composition comprising: a coordination compound comprising a substituted catecholate ligand, the substituted catecholate ligand having a structure of in a neutral form or a salt form; wherein n is an integer ranging between 1 and 4, such that one or more Z are bound to the substituted catecholate ligand at an open aromatic ring position, each Z being the same or different when more than one Z is present; and wherein Z is a heteroatom functional group selected from the group consisting of A 1 R A1 , A 2 R A2 , A 3 R A3 , and CHO; wherein A 1 is —(CH 2 ) a — or —(CHOR)(CH 2 ) a —, R A1 is —OR 1 or —(OCH 2 CH 2 O) b R 1 , a is an integer ranging between 0 and about 6, with the proviso that R 1 is not H when a is 0 and R A1 is —OR 1 , and b is an integer ranging between 1 and about 10; wherein R is H, C 1 -C 6 alkyl, heteroatom-substituted C 1 -C 6 alkyl, or C 1 -C 6 carboxyalkyl; and wherein R 1 is H, methyl, ethyl, a C 2 -C 6 polyol bound through an ether linkage or an ester linkage, or C 1 -C 6 carboxyalkyl; wherein A 2 is —(CH 2 ) c — or —CH(OR 2 )(CH 2 ) d —, R A2 is —NR 3 R 4 , a carbon-linked amino acid, or —C(═O)XR 5 , X is —O— or —NR 6 —, c is an integer ranging between 0 and about 6, and d is an integer ranging between 0 and about 4; wherein R 2 , R 3 , R 4 and R 6 are independently selected from the group consisting of H, C 1 -C 6 alkyl, or heteroatom-substituted C 1 -C 6 alkyl; and wherein R 5 is H, C 1 -C 6 alkyl, heteroatom-substituted C 1 -C 6 alkyl, a C 2 -C 6 polyol bound through an ester linkage, a hydroxyacid bound through an ester linkage, a polyglycol acid bound through an ester linkage, an amino alcohol bound through an ester linkage or an amide linkage, an amino acid bound through an ester linkage or an amide linkage, or —(CH 2 CH 2 O) b R 1 ; and wherein A 3 is —O— or —NR 2 —, R A3 is —(CHR 7 ) e OR 1 , —(CHR 7 ) e NR 3 R 4 , —(CHR 7 ) e C(═O)XR 5 , or —C(═O)(CHR 7 ) f R 8 , e is an integer ranging between 1 and about 6, with the proviso that e is not 1 when A 3 is —O—, and f is an integer ranging between 0 and about 6; wherein R 7 is H or OH; wherein R 8 is H, C 1 -C 6 alkyl, heteroatom-substituted C 1 -C 6 alkyl, a C 2 -C 6 polyol bound through an ether linkage or an ester linkage, a hydroxyacid bound through an ether linkage or an ester linkage, a polyglycol acid bound through an ether linkage or an ester linkage, an amino alcohol bound through an ether linkage, an ester linkage, or an amide linkage, an amino acid bound through an ether linkage, an ester linkage, or an amide linkage, a carbon-linked amino acid, or —(OCH 2 CH 2 O) b R 1 ; wherein the substituted catecholate ligand has a structure selected from the group consisting of wherein the coordination compound has a formula of D g M(L 1 )(L 2 )(L 3 ); wherein M is a transition metal, D is NH 4 + , Li + , Na + , or K + , g is an integer ranging between 0 and 6, and L 1 , L 2 and L 3 are ligands, at least one of L 1 , L 2 and L 3 being the substituted catecholate ligand. 2. The composition of claim 1 , wherein at least two of L 1 , L 2 and L 3 are substituted catecholate ligands. 3. The composition of claim 2 , wherein L 1 and L 2 are substituted catecholate ligands and L 3 is an unsubstituted catecholate ligand. 4. The composition of claim 1 , wherein L 1 is the substituted catecholate ligand and L 2 and L 3 are unsubstituted catecholate ligands. 5. The composition of claim 1 , wherein each of L 1 , L 2 and L 3 are substituted catecholate ligands. 6. The composition of claim 1 , wherein the transition metal is Ti. 7. The composition of claim 1 , wherein any of L 1 to L 3 that are not the unsubstituted catecholate ligand comprises one or more ligands that are independently selected from the group consisting of an unsubstituted catecholate, ascorbate, citrate, glycolate, a polyol, gluconate, a hydroxyalkanoate, acetate, formate, benzoate, malate, maleate, phthalate, sarcosinate, salicylate, oxalate, a urea, a polyamine, aminophenolate, acetylacetonate, and lactate. 8. An electrolyte solution comprising the composition of claim 1 . 9. The electrolyte solution of claim 8 , wherein the electrolyte solution is an aqueous solution. 10. The electrolyte solution of claim 9 , further comprising: a buffer, a supporting electrolyte, a viscosity modifier, a wetting agent, or any combination thereof. 11. The electrolyte solution of claim 9 , wherein the aqueous solution has a pH ranging between about 1 and about 13. 12. The electrolyte solution of claim 9 , wherein the transition metal is Ti. 13. The electrolyte solution of claim 9 , wherein a concentration of the coordination compound in the aqueous solution ranges between about 0.5 M and about 3 M. 14. A flow battery comprising an electrolyte solution comprising the composition of claim 1 . 15. The flow battery of claim 14 , wherein the transition metal is Ti.
Related publications grouped by family.
Answers are generated from the same data shown on this page.